Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 15, Issue 9, Pages 1268-1279
Publisher
Informa UK Limited
Online
2014-06-28
DOI
10.4161/cbt.29691
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chk1 as a new therapeutic target in triple-negative breast cancer
- (2014) Laurence Albiges et al. BREAST
- RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer
- (2014) Õsa Ehlén et al. Translational Oncology
- Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases
- (2013) Valerie Kedinger et al. BMC CANCER
- The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design
- (2013) Ruth Thompson et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Regulatory motifs in Chk1
- (2013) Michael L. Caparelli et al. CELL CYCLE
- Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776
- (2013) C. G. Engelke et al. CLINICAL CANCER RESEARCH
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53
- (2013) M. A. Gadhikar et al. MOLECULAR CANCER THERAPEUTICS
- CHEK again: Revisiting the development of CHK1 inhibitors for cancer therapy
- (2013) S. McNeely et al. PHARMACOLOGY & THERAPEUTICS
- Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection
- (2012) Li Weng et al. Molecular Cancer
- Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer
- (2012) J Xu et al. ONCOGENE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
- (2011) Lucia Migliore et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
- (2011) K. A. Cole et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells
- (2010) N N Kreis et al. ONCOGENE
- Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
- (2009) Ilija Androic et al. BMC CANCER
- Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors
- (2008) Zhan Xiao et al. BIOMARKERS
- CDK inhibitors in cancer therapy: what is next?
- (2007) Marcos Malumbres et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started